Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


23.10.2017

5 Am J Hematol
1 Ann Hematol
7 Blood
1 BMC Cancer
6 Br J Haematol
2 Cancer
1 Cancer Chemother Pharmacol
1 Eur J Haematol
1 Exp Hematol
1 Gene
8 Int J Hematol
1 J Pediatr Hematol Oncol
8 Leuk Lymphoma
2 Leuk Res
1 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. TEFFERI A, Hanson CA, Ketterling RP
    Revisiting the need for bone marrow examination in chronic myeloid leukemia.
    Am J Hematol. 2017 Oct 13. doi: 10.1002/ajh.24942.
    PubMed     Text format    

  2. COOMBS CC, Mathews SP
    Acute promyelocytic leukemia and chronic lymphocytic leukemia diagnosed concurrently.
    Am J Hematol. 2017 Oct 20. doi: 10.1002/ajh.24950.
    PubMed     Text format    

  3. ABAZA Y, Kantarjian HM, Faderl S, Jabbour E, et al
    Hyper-CVAD plus Nelarabine in Newly Diagnosed Adult T-Cell Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma.
    Am J Hematol. 2017 Oct 19. doi: 10.1002/ajh.24947.
    PubMed     Text format     Abstract available

  4. ALHURAIJI A, Kantarjian H, Boddu P, Ravandi F, et al
    Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors.
    Am J Hematol. 2017 Oct 13. doi: 10.1002/ajh.24943.
    PubMed     Text format     Abstract available

  5. KHODER A, Al Obaidi M, Wiles N, Nadal-Melsio E, et al
    Lymphoplasmacytoid cytology in plasma cell leukemia.
    Am J Hematol. 2017 Oct 13. doi: 10.1002/ajh.24940.
    PubMed     Text format    


    Ann Hematol

  6. GUTIERREZ-AGUIRRE CH, Flores-Jimenez JA, Alatorre-Ricardo J, Cantu-Rodriguez OG, et al
    The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study.
    Ann Hematol. 2017 Oct 13. doi: 10.1007/s00277-017-3142.
    PubMed     Text format     Abstract available


    Blood

  7. MARLEIN CR, Zaitseva L, Piddock RE, Robinson SD, et al
    NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts.
    Blood. 2017;130:1649-1660.
    PubMed     Text format     Abstract available

  8. BOBROWICZ M, Dwojak M, Pyrzynska B, Stachura J, et al
    HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies.
    Blood. 2017;130:1628-1638.
    PubMed     Text format     Abstract available

  9. ODA SK, Daman AW, Garcia NM, Wagener F, et al
    A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T cell function and therapy of murine leukemia.
    Blood. 2017 Oct 17. pii: blood-2017-04-777052. doi: 10.1182/blood-2017-04-777052
    PubMed     Text format     Abstract available

  10. TIAO G, Improgo MR, Tausch E, Fernandes SM, et al
    Analysis of ITGB2 rare germline variants in chronic lymphocytic leukemia.
    Blood. 2017 Oct 19. pii: blood-2017-08-800128. doi: 10.1182/blood-2017-08-800128
    PubMed     Text format    

  11. PETIT A, Trinquand A, Chevret S, Ballerini P, et al
    Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-Cell Acute Lymphoblastic Leukemia.
    Blood. 2017 Oct 19. pii: blood-2017-04-778829. doi: 10.1182/blood-2017-04-778829
    PubMed     Text format     Abstract available

  12. DOSSA RG, Cunningham T, Sommermeyer D, Medina-Rodriguez I, et al
    Development of T cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.
    Blood. 2017 Oct 19. pii: blood-2017-07-791608. doi: 10.1182/blood-2017-07-791608
    PubMed     Text format     Abstract available

  13. HARANKHEDKAR S, Gupta R
    MPO-negative inclusions and Auer rod-like structures in a case of acute myeloid leukemia with t(8;21).
    Blood. 2017;130:1869.
    PubMed     Text format    


    BMC Cancer

  14. TRAN LT, Lai HTM, Koriyama C, Uwatoko F, et al
    The association between high birth weight and the risks of childhood CNS tumors and leukemia: an analysis of a US case-control study in an epidemiological database.
    BMC Cancer. 2017;17:687.
    PubMed     Text format     Abstract available


    Br J Haematol

  15. MO XD, Lv M, Huang XJ
    Preventing relapse after haematopoietic stem cell transplantation for acute leukaemia: the role of post-transplantation minimal residual disease (MRD) monitoring and MRD-directed intervention.
    Br J Haematol. 2017;179:184-197.
    PubMed     Text format     Abstract available

  16. HUGHES TP, Munhoz E, Aurelio Salvino M, Ong TC, et al
    Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd.
    Br J Haematol. 2017;179:219-228.
    PubMed     Text format     Abstract available

  17. EDLINGER L, Berger-Becvar A, Menzl I, Hoermann G, et al
    Expansion of BCR/ABL1+ cells requires PAK2 but not PAK1.
    Br J Haematol. 2017;179:229-241.
    PubMed     Text format     Abstract available

  18. STELLRECHT CM, Chen LS, Ayres ML, Dennison JB, et al
    Chlorinated adenosine analogue induces AMPK and autophagy in chronic lymphocytic leukaemia cells during therapy.
    Br J Haematol. 2017;179:266-271.
    PubMed     Text format     Abstract available

  19. ZWAAN CM, Kowalczyk J, Schmitt C, Bielorai B, et al
    Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 study.
    Br J Haematol. 2017 Aug 2. doi: 10.1111/bjh.14874.
    PubMed     Text format     Abstract available

  20. EWINS K, Malone A, Phelan E, Webb D, et al
    Nelarabine-induced peripheral and central neurotoxicity: can sequential MRI brain imaging help to define its natural history?
    Br J Haematol. 2017;179:294-297.
    PubMed     Text format     Abstract available


    Cancer

  21. TIRIBELLI M, Michelutti A, Fanin R, Damiani D, et al
    ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31037.
    PubMed     Text format    

  22. SHORT NJ, Kantarjian H, Jabbour E
    Reply to ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31036.
    PubMed     Text format    


    Cancer Chemother Pharmacol

  23. MCATEE CL, Schneller N, Brackett J, Bernhardt MB, et al
    Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification.
    Cancer Chemother Pharmacol. 2017 Oct 19. doi: 10.1007/s00280-017-3453.
    PubMed     Text format     Abstract available


    Eur J Haematol

  24. DUPLOYEZ N, Abou Chahla W, Lejeune S, Marceau-Renaut A, et al
    Detection of a new heterozygous germline ETV6 mutation in a case with hyperdiploid acute lymphoblastic leukemia (ALL).
    Eur J Haematol. 2017 Oct 16. doi: 10.1111/ejh.12981.
    PubMed     Text format     Abstract available


    Exp Hematol

  25. WILLMANN M, Sadovnik I, Eisenwort G, Entner M, et al
    Evaluation of cooperative anti-leukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia.
    Exp Hematol. 2017 Oct 12. pii: S0301-472X(17)30816.
    PubMed     Text format     Abstract available


    Gene

  26. ZHANG TJ, Lin J, Zhou JD, Li XX, et al
    High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Gene. 2017 Oct 12. pii: S0378-1119(17)30867-3. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    Int J Hematol

  27. KUWATSUKA Y, Tomizawa D, Kihara R, Nagata Y, et al
    Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.
    Int J Hematol. 2017 Oct 12. doi: 10.1007/s12185-017-2340.
    PubMed     Text format     Abstract available

  28. USUI N
    Correction to: JSH guideline for tumors of hematopoietic and lymphoid tissues-lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN).
    Int J Hematol. 2017 Oct 12. doi: 10.1007/s12185-017-2351.
    PubMed     Text format     Abstract available

  29. WANG Y, Xing Y, Chen L, Meng T, et al
    Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
    Int J Hematol. 2017 Oct 13. doi: 10.1007/s12185-017-2342.
    PubMed     Text format     Abstract available

  30. ISHIDA T, Akagawa N, Miyata T, Tominaga N, et al
    Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia.
    Int J Hematol. 2017 Oct 13. doi: 10.1007/s12185-017-2339.
    PubMed     Text format     Abstract available

  31. OKADA Y, Sato K, Kobayashi S, Nagao S, et al
    Sudden blast phase in chronic myeloid leukemia developed during nilotinib therapy after major molecular response was achieved.
    Int J Hematol. 2017 Oct 14. doi: 10.1007/s12185-017-2354.
    PubMed     Text format     Abstract available

  32. KOBAYASHI N, Shimizu H, Hirato J, Handa H, et al
    Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow.
    Int J Hematol. 2017 Oct 17. doi: 10.1007/s12185-017-2356.
    PubMed     Text format    

  33. KOZAKAI T, Takahashi M, Higuchi M, Hara T, et al
    MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia.
    Int J Hematol. 2017 Oct 17. doi: 10.1007/s12185-017-2359.
    PubMed     Text format     Abstract available

  34. HONG CR, Kang HJ, Park KD, Shin HY, et al
    High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia.
    Int J Hematol. 2017 Oct 20. doi: 10.1007/s12185-017-2355.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  35. HILL R, Hamby T, Bashore L, Rapisand S, et al
    Early Nutrition Intervention Attenuates Weight Gain for Pediatric Acute Lymphoblastic Leukemia Patients in Maintenance Therapy.
    J Pediatr Hematol Oncol. 2017 Oct 17. doi: 10.1097/MPH.0000000000000975.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  36. LEE LJ, Toze CL, Huang SJT, Gillan TL, et al
    Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada.
    Leuk Lymphoma. 2017 Oct 16:1-8. doi: 10.1080/10428194.2017.1387904.
    PubMed     Text format     Abstract available

  37. MOTOHASHI K, Fujisawa S, Doki N, Kobayashi T, et al
    Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
    Leuk Lymphoma. 2017 Oct 16:1-6. doi: 10.1080/10428194.2017.1387913.
    PubMed     Text format     Abstract available

  38. CORROCHER FA, Bueno de Paiva L, Duarte ASS, Ferro KP, et al
    Reduced expression of NR4A1 activates glycolytic pathway in acute promyelocytic leukemia cells.
    Leuk Lymphoma. 2017 Oct 17:1-4. doi: 10.1080/10428194.2017.1387900.
    PubMed     Text format    

  39. MITSUI-SEKINAKA K, Sekinaka Y, Ogura Y, Honda M, et al
    A pediatric case of acute megakaryocytic leukemia with double chimeric transcripts of CBFA2T3-GLIS2 and DHH-RHEBL1.
    Leuk Lymphoma. 2017 Oct 18:1-3. doi: 10.1080/10428194.2017.1387901.
    PubMed     Text format    

  40. LI WY, Wang Y, Chen SN, Qiu HY, et al
    Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission.
    Leuk Lymphoma. 2017 Oct 18:1-7. doi: 10.1080/10428194.2017.1390235.
    PubMed     Text format     Abstract available

  41. GEYER MB, Manjunath SH, Evans AG, Park JH, et al
    Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells.
    Leuk Lymphoma. 2017 Oct 18:1-5. doi: 10.1080/10428194.2017.1390237.
    PubMed     Text format    

  42. PENG L, Tang Y, Zhang Y, Guo S, et al
    Structural maintenance of chromosomes 4 is required for leukemia stem cell maintenance in MLL-AF9 induced acute myeloid leukemia.
    Leuk Lymphoma. 2017 Oct 18:1-8. doi: 10.1080/10428194.2017.1387906.
    PubMed     Text format     Abstract available

  43. SALZER W, Bostrom B, Messinger Y, Perissinotti AJ, et al
    Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia.
    Leuk Lymphoma. 2017 Oct 18:1-10. doi: 10.1080/10428194.2017.1386305.
    PubMed     Text format     Abstract available


    Leuk Res

  44. MOHAMMADI SM, Mohammadnejad D, Hosseinpour Feizi AA, Movassaghpour AA, et al
    Inhibition of c-REL using siRNA increased apoptosis and decreased proliferation in pre-B ALL blasts: Therapeutic implications.
    Leuk Res. 2017;61:53-61.
    PubMed     Text format     Abstract available

  45. AIRIAU K, Turcq B, Mahon FX, Belloc F, et al
    A new mechanism of resistance to ABL1 tyrosine kinase inhibitors in a BCR-ABL1-positive cell line.
    Leuk Res. 2017;61:44-52.
    PubMed     Text format     Abstract available


    Oncol Rep

  46. SHEN Y, Liu Q, Lou S, Luo Y, et al
    Decreased expression of the augmenter of liver regeneration results in growth inhibition and increased chemosensitivity of acute T lymphoblastic leukemia cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5984.
    PubMed     Text format     Abstract available


    PLoS One

  47. LI S, Jin X, Wu H, Wang Y, et al
    HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6.
    PLoS One. 2017;12:e0180142.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: